AKT1 and leukemia: We observed an exuberant expression of CD122, Galectin-9, and PD-L1 in HL60 cells ( Figure 4A , gray bars), and found that AKT inhibition primarily decreased the surface expression of these immune checkpoint molecules in leukemia cells ( Figure 4A , black bars).